Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma

This research trial studies late effects after treatment in patients with previously diagnosed high-risk neuroblastoma. Studying late effects after treatment may help to decide which treatments for high-risk neuroblastoma are better tolerated with less side effects over time.

Research Base: Children's Oncology Group
NCT ID: NCT03057626
NCI Protocol Number: COG-ALTE15N2
Status: Recruiting

For more information see ClinicalTrials.gov

Interventions

Cytology Specimen Collection Procedure; Laboratory Biomarker Analysis; Quality-of-Life Assessment

Condition

Recurrent Neuroblastoma, Stage 2A Neuroblastoma, Stage 2B Neuroblastoma, Stage 3 Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma

Trial Type

Supportive Care/Symptom Management/PROs

See a list of participating sites on ClinicalTrials.gov


˄
BACK TO
TOP